Skip to main content
Erschienen in: Journal of Gastroenterology 7/2016

26.05.2016 | Editorial

Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”

verfasst von: Atsushi Tanaka, Hajime Takikawa, Satoshi Mochida, Kazuhiko Koike, Hiroto Miwa, Toru Shimosegawa

Erschienen in: Journal of Gastroenterology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Excerpt

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease, frequently developing in middle-aged women [1]. In patients with PBC, small bile ducts in the liver are believed to be damaged via autoimmune reactions [2]. Patients were diagnosed as having PBC when 2 or more among the following 3 features are observed; elevated cholestatic enzymes, presence of anti-mitochondrial autoantibodies (AMA) and histological findings as chronic non-suppurative destructive cholangitis (CNSDC) in particular [3]. When the disease entity of PBC was established more than 50 years ago [4], advanced liver diseases showing histological findings of cirrhosis were found in the most of patients with PBC. Consequently, a nomenclature for primary biliary “cirrhosis” was reasonably accepted by all hepatologists and gastroenterologists world-widely. …
Literatur
1.
Zurück zum Zitat Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015; 17; 386(10003):1565-75. Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015; 17; 386(10003):1565-75.
2.
Zurück zum Zitat Gershwin ME, Ansari A, Mackay I, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000;174:210–25.CrossRefPubMed Gershwin ME, Ansari A, Mackay I, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000;174:210–25.CrossRefPubMed
3.
Zurück zum Zitat Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis. Guidelines for the management of primary biliary cirrhosis: the intractable hepatobiliary disease study group supported by the Ministry of health, labour and welfare of Japan. Hepatol Res. 2014;44 (Suppl S1):71–90. Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis. Guidelines for the management of primary biliary cirrhosis: the intractable hepatobiliary disease study group supported by the Ministry of health, labour and welfare of Japan. Hepatol Res. 2014;44 (Suppl S1):71–90.
5.
Zurück zum Zitat Gershwin ME, Mackay I, Sturgess A, et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987;138:3525–31.PubMed Gershwin ME, Mackay I, Sturgess A, et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987;138:3525–31.PubMed
6.
Zurück zum Zitat Abbas G, Lindor KD. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid. Expert Opin Pharmacother. 2010;11:387–92.CrossRefPubMed Abbas G, Lindor KD. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid. Expert Opin Pharmacother. 2010;11:387–92.CrossRefPubMed
7.
Zurück zum Zitat Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. J Hepatol. 2015;63:1285–7.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. J Hepatol. 2015;63:1285–7.CrossRefPubMed
8.
Zurück zum Zitat Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. Hepatology. 2015;62:1620–2.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. Hepatology. 2015;62:1620–2.CrossRefPubMed
9.
Zurück zum Zitat Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Gastroenterology. 2015;149:1627–9.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Gastroenterology. 2015;149:1627–9.CrossRefPubMed
10.
Zurück zum Zitat Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’. Gut. 2015;64:1671–2.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’. Gut. 2015;64:1671–2.CrossRefPubMed
11.
Zurück zum Zitat Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Am J Gastroenterol. 2015;110:1536–8.CrossRefPubMedPubMedCentral Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Am J Gastroenterol. 2015;110:1536–8.CrossRefPubMedPubMedCentral
Metadaten
Titel
Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”
verfasst von
Atsushi Tanaka
Hajime Takikawa
Satoshi Mochida
Kazuhiko Koike
Hiroto Miwa
Toru Shimosegawa
Publikationsdatum
26.05.2016
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 7/2016
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-016-1223-z

Weitere Artikel der Ausgabe 7/2016

Journal of Gastroenterology 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.